Subcutaneous Immunoglobulin

Global Market Trajectory & Analytics

MCP16833

EXECUTIVE ENGAGEMENTS

POOL

686
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

137
Interactions with Platform & by Email

PARTICIPANTS

27
Unique # Participated

VALIDATIONS

11
Responses Validated*

COMPANIES

46
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

102

PAGES

178

EDITION

9

PRICE

USD 4950

CODE

MCP16833


COMPETITIVE METRICS

COMPANY

D S N T

% *

Biotest AG

CSL Behring

Grifols International SA

Kedrion SpA

Octapharma AG

Shire PLC

*Login to Participate & View Data Stacks
View 46 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Subcutaneous Immunoglobulin estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$9.3 Billion by 2027, growing at aCAGR of 13.5% over the period 2020-2027. Primary Immunodeficiency Diseases, one of the segments analyzed in the report, is projected to record 14.6% CAGR and reach US$7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Secondary Immunodeficiency Diseases segment is readjusted to a revised 10.5% CAGR for the next 7-year period.
The Subcutaneous Immunoglobulin market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 11.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

SELECT PLAYERS

Biotest AG; CSL Behring; Grifols International SA; Grifols SA; Kedrion SpA; Octapharma AG; Shire PLC

SEGMENTS

» Application (Primary Immunodeficiency Diseases, Secondary Immunodeficiency Diseases) » End-Use (Hospitals, Clinics, Homecare Settings)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Subcutaneous Immunoglobulin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Subcutaneous Immunoglobulin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Subcutaneous Immunoglobulin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Primary Immunodeficiency Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Primary Immunodeficiency Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Primary Immunodeficiency Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Secondary Immunodeficiency Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Secondary Immunodeficiency Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Secondary Immunodeficiency Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Homecare Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Homecare Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
China Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Subcutaneous Immunoglobulin by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Subcutaneous Immunoglobulin by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Subcutaneous Immunoglobulin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
France Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Subcutaneous Immunoglobulin by Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Subcutaneous Immunoglobulin by Application - Percentage Breakdown of Value Sales for Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Subcutaneous Immunoglobulin by End-Use - Hospitals, Clinics and Homecare Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Subcutaneous Immunoglobulin by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Homecare Settings for the Years 2012, 2020 & 2027
Total Companies Profiled: 46

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com